N-(Piperidin-4-yl)benzenesulfonamide hydrochloride
- $289 - $572
- Product name: N-(Piperidin-4-yl)benzenesulfonamide hydrochloride
- CAS: 68996-29-2
- MF: C11H17ClN2O2S
- MW: 276.78288
- EINECS:
- MDL Number:MFCD13689304
- Synonyms:N-(Piperidin-4-yl)benzenesulfonamide hydrochloride
5 prices
Selected condition:
Brand
- AK Scientific
- Chemenu
- Crysdot
Package
- 100mg
- 1g
- 2.5g
- ManufacturerAK Scientific
- Product number4538DK
- Product descriptionN-(Piperidin-4-yl)benzenesulfonamidehydrochloride
- Packaging100mg
- Price$289
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number4538DK
- Product descriptionN-(Piperidin-4-yl)benzenesulfonamidehydrochloride
- Packaging1g
- Price$368
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number4538DK
- Product descriptionN-(Piperidin-4-yl)benzenesulfonamidehydrochloride
- Packaging2.5g
- Price$572
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM317596
- Product descriptionN-(Piperidin-4-yl)benzenesulfonamidehydrochloride 95%
- Packaging1g
- Price$350
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11072004
- Product descriptionN-(Piperidin-4-yl)benzenesulfonamidehydrochloride 95+%
- Packaging1g
- Price$370
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 4538DK | N-(Piperidin-4-yl)benzenesulfonamidehydrochloride | 100mg | $289 | 2021-12-16 | Buy |
AK Scientific | 4538DK | N-(Piperidin-4-yl)benzenesulfonamidehydrochloride | 1g | $368 | 2021-12-16 | Buy |
AK Scientific | 4538DK | N-(Piperidin-4-yl)benzenesulfonamidehydrochloride | 2.5g | $572 | 2021-12-16 | Buy |
Chemenu | CM317596 | N-(Piperidin-4-yl)benzenesulfonamidehydrochloride 95% | 1g | $350 | 2021-12-16 | Buy |
Crysdot | CD11072004 | N-(Piperidin-4-yl)benzenesulfonamidehydrochloride 95+% | 1g | $370 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|